Systematic Analysis of Protein Targets Associated with Adverse Events of Drugs from Clinical Trials and Postmarketing Reports

Related articles

1. Clinical Impact of Pharmacogenetic Risk Variants in a Large Chinese Cohort

   This article has 123 authors:

   1. Pui-Yan Kwok
   2. Ming-Shien Wen
   3. Chih-Kuang Cheng
   4. Yi-Jing Sheen
   5. Tsung-Chieh Yao
   6. Sing-Lian Lee
   7. Jer-Yuarn Wu
   8. Ming-Fang Tsai
   9. Ling-Hui Li
   10. Chun-houh Chen
   11. Cathy S.-J. Fann
   12. Hsin-Chou Yang
   13. Yen-Tsung Huang
   14. Hung-Hsin Chen
   15. Yi-Min Liu
   16. Erh-Chan Yeh
   17. Yu-Ching Peng
   18. Shuu-Jiun Wang
   19. Shih-Pin Chen
   20. Ming-Tsun Tsai
   21. Teh-Ia Huo
   22. Chien-Wei Su
   23. Der-Cherng Tarng
   24. Chin-Chou Huang
   25. Jong-Ling Fuh
   26. Keng-Hsin Lan
   27. Yo-Tsen Liu
   28. Ching-Liang Lu
   29. Yi-Chung Lee
   30. Yi-Hsiang Huang
   31. Chung-Pin Li
   32. Yen-Feng Wang
   33. Yu-Cheng Hsieh
   34. Yi-Ming Chen
   35. Tzu-Hung Hsiao
   36. Ching‐Heng Lin
   37. Yen-Ju Chen
   38. I-Chieh Chen
   39. Chien-Lin Mao
   40. Shu-Jung Chang
   41. Yen-Lin Chang
   42. Yi‐Ju Liao
   43. Chih-Hung Lai
   44. Wei-Ju Lee
   45. Hsin Tung
   46. Ting-Ting Yen
   47. Hsin-Chien Yen
   48. Jer-Hwa Chang
   49. Chun-Yao Huang
   50. Lung Chan
   51. Yung-Wei Lin
   52. Bu-Yuan Hsiao
   53. Chaur-Jong Hu
   54. Yung-Kuo Lin
   55. Yung-Feng Lin
   56. Tung-Cheng Chang
   57. Deng-Chyang Wu
   58. Jung-Yu Kan
   59. CHUNG YAO HSU
   60. Szu-Chia Chen
   61. Ching-Chia Li
   62. Chung-Feng Huang
   63. Chua-Chyun Sheu
   64. Lii-Jia Yang
   65. Chung-Hwan Chen
   66. Kuan-Mao Chen
   67. Shu-Min Chang
   68. Min-Shiuan Liou
   69. Shi-Ping Wang
   70. Kuan-Ting Lin
   71. Hui-Ping Chuang
   72. Ying-Ju Chen
   73. Joey Sin
   74. Ying-Ting Chen
   75. Chiung-Chih Chang
   76. Chang-Fu Kuo
   77. Jing-Chi Lin
   78. Ho-Chang Kuo
   79. Tien-Min Chan
   80. Chao-Wei Lee
   81. Jenn-Haung Lai
   82. Shue-Fen Luo
   83. Hao-Tsai Cheng
   84. Lian-Yu Lin
   85. Li-Chun Chang
   86. Chia-Ti Tsai
   87. Hsien-Li Kao
   88. Jian-Jyun Yu
   89. Jiann-Shing Jeng
   90. Min-Chin Chiu
   91. Tzu-Chan Hong
   92. Shun-Fa Yang
   93. Hsueh-Ju Lu
   94. Sheng-Chiang Su
   95. Pauling Chu
   96. Peng-Fei Li
   97. Chia-Lin Tsai
   98. Chia-Kuang Tsai
   99. Shih-En Tang
   100. Chien-Ming Lin
   101. Yung-Fu Wu
   102. Chih-Yang Huang
   103. Shinn-Zong Lin
   104. Chun-Chun Chang
   105. Tzu-Kai Lin
   106. Sheng-Mou Hsiao
   107. Chih-Hung Chang
   108. Chih-Dao Chen
   109. Gwo-Chin Ma
   110. Ting-Yu Chang
   111. Juey-Jen Hwang
   112. Chien-Lin Lu
   113. Kuo-Jang Kao
   114. Chen-Fang Hung
   115. Shiou-Sheng Chen
   116. Po-Yueh Chen
   117. Kochung Tsui
   118. Chien-Hsiun Chen
   119. Chih-Cheng Chien
   120. Han-Sun Chiang
   121. Yen-Ling Chiu
   122. Hsiang-Cheng Chen
   123. Chun-yu Wei

2. The Role of Pharmacometrics in Advancing the Therapies for Autoimmune Diseases

   This article has 3 authors:

   1. Artur Świerczek
   2. Dominika Batko
   3. Elżbieta Wyska

3. Postmarketing safety of eltrombopag olamine : an analysis of the FDA Adverse Event Reporting System (FAERS)

   This article has 4 authors:

   1. Kun Wang
   2. Peipei Xu
   3. Sheng Lu
   4. Bin Yao